Significant Ownership of Ayala Pharmaceuticals, Inc.

Signature - Title
/s/ Sarit Steinberg - Sarit Steinberg /President
Location
Monmouth Junction, NJ
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ayala Pharmaceuticals, Inc..

Notify me when Ayala Pharmaceuticals, Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Ayala Pharmaceuticals, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OSTX OS Therapies Incorporated Common Stock, par value $0.001 per share 10% $4,328,430 2,164,215 AYALA PHARMACEUTICALS, INC. 09 Apr 2025

Schedules 13D/G Reported by Ayala Pharmaceuticals, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.